These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6614876)

  • 1. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Granato JE; Stern BJ; Ringel A; Karim AH; Krumholz A; Coyle J; Adler S
    Ann Neurol; 1983 Jul; 14(1):89-90. PubMed ID: 6614876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the neuroleptic malignant syndrome with bromocriptine.
    Dhib-Jalbut S; Hesselbrock R; Brott T; Silbergeld D
    JAMA; 1983 Jul 22-29; 250(4):484-5. PubMed ID: 6134848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroleptic malignant syndrome. A priority system.
    Neppe VM
    S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dantrolene sodium as a possible prophylactic agent against N.M.S.
    Lesser MS; Kahan M; Brenner R; Nayak D
    Hillside J Clin Psychiatry; 1986; 8(1):34-7. PubMed ID: 3744298
    [No Abstract]   [Full Text] [Related]  

  • 7. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
    Smidt MH; Collumbien EC
    Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A; Jaffe JH; Nelson WH; Morrison B
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts. Neuroleptic malignant syndrome.
    Guzé BH; Baxter LR
    N Engl J Med; 1985 Jul; 313(3):163-6. PubMed ID: 3892294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
    Mueller PS; Vester JW; Fermaglich J
    JAMA; 1983 Jan; 249(3):386-8. PubMed ID: 6129331
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A; Quitkin F; Kane J; Klein DF
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a case of neuroleptic malignant syndrome with bromocriptine.
    Zubenko G; Pope HG
    Am J Psychiatry; 1983 Dec; 140(12):1619-20. PubMed ID: 6650696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protracted recurrent neuroleptic malignant syndrome].
    Delerue O; Destée A
    Rev Neurol (Paris); 1990; 146(8-9):515-7. PubMed ID: 2237099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine].
    Verhoeven WM; Elderson A
    Ned Tijdschr Geneeskd; 1985 Jan; 129(2):76-8. PubMed ID: 3969176
    [No Abstract]   [Full Text] [Related]  

  • 20. Questions about dantrolene for neuroleptic malignant syndrome.
    Henderson VW
    Am J Psychiatry; 1983 Jan; 140(1):137-9. PubMed ID: 6128926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.